Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Panmira Pharmaceuticals LLC
DescriptionOral prostaglandin D2 (PGD2) receptor (CRTH2) subtype DP2 antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2) (CRTH2) (GPR44) (DP2) (CD294)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma and chronic obstructive pulmonary disease (COPD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today